Status:
UNKNOWN
Evaluation of Use of Diagnostic AI for Lung Cancer in Practice
Lead Sponsor:
Ensemble Group Holdings, LLC
Conditions:
Lung Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study investigates ways of improving radiologists performance of the classification of CT-scans as cancerous or non-cancerous. Participants interact with an AI to classify CT-scans under three di...
Detailed Description
The three conditions are as follows: "probabilistic classification", where the radiologist diagnoses scans using an AI cancer likelihood score; "classification plus detection", where the radiologist s...
Eligibility Criteria
Inclusion
- The participant performs radiology screenings professionally
Exclusion
- \-
Key Trial Info
Start Date :
December 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03780582
Start Date
December 14 2018
End Date
December 15 2019
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hong Kong
Hong Kong, Hong Kong